Jens Peter Nørgaard awarded prestigious professorship at University of Lund

Jens Peter Nørgaard awarded prestigious professorship at University of Lund
28 April 2005 pulse

Jens Peter Nørgaard awarded prestigious professorship at University of Lund

Copenhagen, Denmark– 28 April, 2005 –

Jens Peter Nørgaard, Ferring’s chief scientific officer for urology in clinical research and development, has been awarded the prestigious Adjunct Professorship of Urology at the University of Lund, Sweden.

Jens Peter, who has specialised in urology and paediatric surgery since qualifying as a medical doctor in 1981, will combine the professorship with his current role at Ferring in Copenhagen, where he has worked since 1997.

Jens Peter is one of the most respected names in the field of urology and completed a thesis on primary nocturnal enuresis in 1990 which has been widely published and referenced in the field. He was also founder of the International Children’s Continence Society (ICCS) and continues as an active member of this organisation.

Anders Mattiasson, Professor of Urology at Lund University welcomed the appointment, commenting that “Jens Peter has an excellent reputation in the field of urology and we look forward to working closely with him.

“It is the fulfilment of a long and fruitful partnership between the university’s urology department and Ferring,” he added “and it supports the Medicon Valley Academy’s objective of building bridges between the pharmaceutical industry, academia and hospitals.”

Pascal Danglas, Ferring’s executive vice president of clinical and product development, echoed Professor Mattiasson’s views. “We have had an excellent relationship with the University for many years, and we are enthusiastic about the contribution Jens Peter can make in bringing closer cooperation between the industry, universities and the public health sector.”

About Ferring Pharmaceuticals

Ferring is a Swiss-based research driven, speciality biopharmaceutical group active in global markets.
The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology, infertility and urology.

In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.

To learn more about Ferring or our products please visit us at

For more information, please contact

Michael George
Corporate Communication Manager
+45 2878 72 09

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.


Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.


Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals


Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.


Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.


Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.